Targeting immunoglobulin E in non-atopic asthma: crossing the red line?

Mina Gaga, Eleftherios Zervas, Marc Humbert

Source: Eur Respir J 2016; 48: 1538-1540
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mina Gaga, Eleftherios Zervas, Marc Humbert. Targeting immunoglobulin E in non-atopic asthma: crossing the red line?. Eur Respir J 2016; 48: 1538-1540

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation between total serum immunoglobulin E and allergen specific immunoglobulin E in children with allergic disease
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009

Allergic basis of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=74
Year: 2003

High affinity receptor for immunoglobulin E (FcER1-β) gene polymorphisms in Turkish allergic asthmatic subgroups
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009


Pathogenesis of occupational asthma
Source: Eur Respir J 2003; 22: 364-373
Year: 2003



Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
Source: Eur Respir Rev 2008; 17: 1-9
Year: 2008



Association of asthma and total IgE levels with human leucocyte antigen-DR in patients with grass allergy
Source: Eur Respir J 2002; 20: 79-85
Year: 2002



Vitamin D in asthma and allergy: what next?
Source: Eur Respir J 2011; 38: 1255-1257
Year: 2011


Targeting atopic inflammation: anti-IgE treatment
Source: Annual Congress 2007 - Novel therapies for severe asthma
Year: 2007


Targeting neutrophils in asthma: a strategy shared with COPD?
Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma?
Year: 2012


Association between blood eosinophil count and control of allergic rhinitis: does it exist?
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Serum immunoglobulin E (IgE) in COPD: analysis of the German COSYCONET cohort
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Total IgE and Der p 1 (D1) specific IgE in induced sputum (IS) in patients with allergic and non-allergic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Immunoglobulin G and subclasses in COPD exacerbator phenotype: levels in exacerbation time and clinical stability
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


The effect of inhaled glucocortycoid therapy on immunoglobulin E in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 132s
Year: 2004

Hypersensitivity skin-prick test with common allergens, immunoglobulin E level and their genetic association with interleukin 13 among asthmatics in Sudan
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


The rationale for treating allergic asthma with anti-IgE
Source: Eur Respir Rev 2007; 16: 61-66
Year: 2007



How to evaluate a patient's response to anti-IgE
Source: Eur Respir Rev 2007; 16: 78-84
Year: 2007



Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics
Source: Eur Respir J 2001; 17: 59-63
Year: 2001